Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alexza Pharmaceuticals, Inc.
Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates
May 30th, 2008
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) reported financial results for its fiscal quarter ended March 31, 2008 and provided an update on the Company's progress with its product candidates. The net loss for the 2008 first fiscal quarter, as reported in accordance with accounting principles generally accepted in the United States (GAAP), was $14.6 million, compared to a net loss of $10.9 million in the comparable period in 2007. Alexza had consolidated cash, cash equivalents and marketable securities (including investments held by Symphony Allegro) at March 31, 2008 of $111.7 million. "The first four months of 2008 have been very productive for Alexza, as we have...
Source: Health Business Week (2008-05-30)
|
